Sherif Mostafa

Sherif Mostafa

Auto-generated profile, based on publicly available information

Sherif Mostafa

Department of Internal Medicine, Hamad General Hospital, Hamad Medical Corporation, Doha, Qatar, hamad.qa

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2025 in Case Reports in Hepatology
Verified
Journal Article
Open access
GKGi Eun Kim
Gi Eun Kim
MIMariam Imran
Mariam Imran
SMSherif Mostafa
Sherif Mostafa
YKYasser Kamel
Yasser Kamel
Primary biliary cholangitis is a progressive disease with complications such as liver cirrhosis and hepatocellular carcinoma, and the treatment goal is to delay its progression. One of the markers for treatment response is alkaline phosphatase levels. Baricitinib has been used in one randomized controlled trial involving two patients to improve outcomes in unresponsive primary biliary cholangitis. We present a case of primary biliary cholangitis who had incomplete response to ursodeoxycholic acid, obeticholic acid, and fenofibrate but showed complete response to baricitinib in terms of sustained normalized alkaline phosphatase levels.